86 related articles for article (PubMed ID: 8986620)
1. Spontaneous apoptosis of thymocytes is uncoupled with progression through the cell cycle.
Pellicciari C; Bottone MG; Schaack V; Barni S; Manfredi AA
Exp Cell Res; 1996 Dec; 229(2):370-7. PubMed ID: 8986620
[TBL] [Abstract][Full Text] [Related]
2. Etoposide at different concentrations may open different apoptotic pathways in thymocytes.
Pellicciari C; Bottone MG; Schaack V; Manfredi AA; Barni S
Eur J Histochem; 1996; 40(4):289-98. PubMed ID: 9116336
[TBL] [Abstract][Full Text] [Related]
3. Differential sensitivity to the induction of apoptosis by cisplatin in proliferating and quiescent immature rat thymocytes is independent of the levels of drug accumulation and DNA adduct formation.
Evans DL; Tilby M; Dive C
Cancer Res; 1994 Mar; 54(6):1596-603. PubMed ID: 8137265
[TBL] [Abstract][Full Text] [Related]
4. Elevated proliferating cell nuclear antigen levels in immature thymocytes. Dissociation from cell cycle progression.
Turka LA; Gratiot-Deans J; Keim D; Bandukwala R; Green J; Strahler J; Hanash SM
J Immunol; 1993 Apr; 150(7):2746-52. PubMed ID: 8095955
[TBL] [Abstract][Full Text] [Related]
5. The cell cycle phases of DNA damage and repair initiated by topoisomerase II-targeting chemotherapeutic drugs.
Potter AJ; Rabinovitch PS
Mutat Res; 2005 May; 572(1-2):27-44. PubMed ID: 15790488
[TBL] [Abstract][Full Text] [Related]
6. A single-step staining procedure for the detection and sorting of unfixed apoptotic thymocytes.
Pellicciari C; Manfredi AA; Bottone MG; Schaack V; Barni S
Eur J Histochem; 1993; 37(4):381-90. PubMed ID: 7510545
[TBL] [Abstract][Full Text] [Related]
7. Investigation of the mechanism of higher order chromatin fragmentation observed in drug-induced apoptosis.
Beere HM; Chresta CM; Alejo-Herberg A; Skladanowski A; Dive C; Larsen AK; Hickman JA
Mol Pharmacol; 1995 May; 47(5):986-96. PubMed ID: 7746285
[TBL] [Abstract][Full Text] [Related]
8. Apoptosis of unstimulated human lymphocytes and DNA strand breaks induced by the topoisomerase II inhibitor etoposide (VP-16).
Tronov VA; Konoplyannikov MA; Nikolskaya TA; Konstantinov EM
Biochemistry (Mosc); 1999 Mar; 64(3):345-52. PubMed ID: 10205305
[TBL] [Abstract][Full Text] [Related]
9. Flow cytometric analysis of CD3/TCR complex, zinc, and glucocorticoid-mediated regulation of apoptosis and cell cycle distribution in thymocytes from old mice.
Provinciali M; Di Stefano G; Stronati S
Cytometry; 1998 May; 32(1):1-8. PubMed ID: 9581618
[TBL] [Abstract][Full Text] [Related]
10. Differential cytotoxic pathways of topoisomerase I and II anticancer agents after overexpression of the E2F-1/DP-1 transcription factor complex.
Hofland K; Petersen BO; Falck J; Helin K; Jensen PB; Sehested M
Clin Cancer Res; 2000 Apr; 6(4):1488-97. PubMed ID: 10778981
[TBL] [Abstract][Full Text] [Related]
11. Apoptosis of androgen-independent mammary and prostate cell lines induced by topoisomerase inhibitors: common pathway of gene regulation.
Furuya Y; Ohta S; Ito H
Anticancer Res; 1997; 17(3C):2089-93. PubMed ID: 9216669
[TBL] [Abstract][Full Text] [Related]
12. Complex response of breast epithelial cell lines to topoisomerase inhibitors.
Davis PL; Shaiu WL; Scott GL; Iglehart JD; Hsieh TS; Marks JR
Anticancer Res; 1998; 18(4C):2919-32. PubMed ID: 9713486
[TBL] [Abstract][Full Text] [Related]
13. Topoisomerase IIalpha mediates E2F-1-induced chemosensitivity and is a target for p53-mediated transcriptional repression.
Nip J; Hiebert SW
Cell Biochem Biophys; 2000; 33(2):199-207. PubMed ID: 11325040
[TBL] [Abstract][Full Text] [Related]
14. Topoisomerase II inhibitor-induced apoptosis in thymocytes and lymphoma cells.
Kizaki H; Onishi Y
Adv Enzyme Regul; 1997; 37():403-23. PubMed ID: 9381984
[TBL] [Abstract][Full Text] [Related]
15. Oncogenic transformation potentiates apoptosis, S-phase arrest and stress-kinase activation by etoposide.
Chen G; Shu J; Stacey DW
Oncogene; 1997 Oct; 15(14):1643-51. PubMed ID: 9349497
[TBL] [Abstract][Full Text] [Related]
16. An inducible lymphocyte nuclear Ca2+/Mg(2+)-dependent endonuclease associated with apoptosis.
Khodarev NN; Ashwell JD
J Immunol; 1996 Feb; 156(3):922-31. PubMed ID: 8558018
[TBL] [Abstract][Full Text] [Related]
17. Selection of human leukemic CEM cells for resistance to the DNA topoisomerase II catalytic inhibitor ICRF-187 results in increased levels of topoisomerase IIalpha and altered G(2)/M checkpoint and apoptotic responses.
Morgan SE; Cadena RS; Raimondi SC; Beck WT
Mol Pharmacol; 2000 Feb; 57(2):296-307. PubMed ID: 10648639
[TBL] [Abstract][Full Text] [Related]
18. Specific resistance of T cells to CD95-induced apoptosis during S phase of the cell cycle.
Dao T; Huleatt JW; Hingorani R; Crispe IN
J Immunol; 1997 Nov; 159(9):4261-7. PubMed ID: 9379021
[TBL] [Abstract][Full Text] [Related]
19. Apoptosis may be either suppressed or enhanced with strategic combinations of antineoplastic drugs or anti-IgM.
Lin CK; Nguyen TT; Morgan TL; Mei RL; Kaptein JS; Kalunta CI; Yen CF; Park E; Zou HY; Lad PM
Exp Cell Res; 1998 Oct; 244(1):1-13. PubMed ID: 9770343
[TBL] [Abstract][Full Text] [Related]
20. Biochemical and morphological identification of ceramide-induced cell cycle arrest and apoptosis in cultured granulosa cells.
Kim JH; Han JS; Yoon YD
Tissue Cell; 1999 Dec; 31(6):531-9. PubMed ID: 10669928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
